Health
U.K. says study supports delaying 2nd COVID-19 vaccine dose – Los Angeles Times
A study finds that the AstraZeneca-Oxford University vaccine cut coronavirus transmission by two-thirds and prevented COVID-19.
Britains health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks, saying it supports the governments contentious strategy of delaying the second shot so it can protect more people quickly with a first dose.
Britains decision has been criticized as risky by other European countries, but Health Secretary Matt Hancock said Wednesday that the study backs the strategy that weve taken, and it shows the…
-
General16 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Business22 hours ago3 of the best ASX ETFs for beginners to buy with $1,000
-
Business20 hours agoWhy this ASX 200 tech stock could rise 20%
-
Business23 hours ago$10,000 invested in Woodside shares 4 years ago is now worth…